Fernand Labrie

Papers

Total Citations

H-Index

About

Fernand Labrie is a pioneering endocrinologist whose groundbreaking research has fundamentally reshaped the understanding and treatment of hormone-sensitive cancers, particularly prostate cancer. His major contributions center on elucidating the role of the hypothalamic-pituitary-gonadal axis in cancer growth, leading to the development of luteinizing hormone-releasing hormone (LHRH) agonists—a therapeutic revolution that became the gold standard for advanced prostate cancer. Labrie’s work demonstrated that combined androgen blockade (CAB) significantly improves patient survival, a finding that has influenced clinical practice worldwide. His influential paper, "High risk genes predisposing to prostate cancer development—do they exist?" (2000, 25 citations), critically examined genetic susceptibility, sparking debate and further research into hereditary risk factors. Beyond this, his prolific career has yielded over 1,000 publications and more than 30,000 citations, underscoring his immense impact. Recognized with numerous international awards, including the prestigious Prix Galien, Labrie’s legacy endures in the millions of patients who have benefited from his insights into hormonal regulation and cancer therapy.